Lumina Fund Management LLC Gilead Sciences, Inc. Transaction History

Lumina Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $821,425 - $935,975	-14,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $900,450 - $1.13 Million	14,500 New	14,500 $916,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $509,880 - $621,600	-7,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $504,770 - $598,290	7,000	7,000 $567,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lumina Fund Management LLC with notifications on news.